Cevenini, Monica
(2022)
Elastography Point Quantification in the evaluation of liver fibrosis in NAFLD patients, [Dissertation thesis], Alma Mater Studiorum Università di Bologna.
Dottorato di ricerca in
Scienze chirurgiche, 34 Ciclo. DOI 10.48676/unibo/amsdottorato/10112.
Documenti full-text disponibili:
|
Documento PDF (English)
- Richiede un lettore di PDF come Xpdf o Adobe Acrobat Reader
Disponibile con Licenza: Salvo eventuali più ampie autorizzazioni dell'autore, la tesi può essere liberamente consultata e può essere effettuato il salvataggio e la stampa di una copia per fini strettamente personali di studio, di ricerca e di insegnamento, con espresso divieto di qualunque utilizzo direttamente o indirettamente commerciale. Ogni altro diritto sul materiale è riservato.
Download (516kB)
|
Abstract
Non-alcoholic fatty liver disease (NAFLD) is the most common cause of chronic liver disease. Several non-invasive approaches to stage liver fibrosis in NAFLD patients are being developed. Elastography Point Quantification (ElastPQ) is a non-invasive method to assess liver fibrosis measuring liver stiffness.
We evaluated the diagnostic performance of ElastPQ for identifying different degrees of fibrosis in NAFLD patients. We compared ElastPQ with other non-invasive tests and identify the best liver stiffness cut offs for every fibrosis stage.
ElastPQ was performed in a training cohort of patients with biopsy-proved NAFLD, liver serum tests and Transient Elastography (TE). The diagnostic performance of ElastPQ was evaluated using AUROC and compared with TE, Fibrosis-4 score, NAFLD fibrosis score and AST/ALT. ElastPQ was performed in a validation cohort in order to validate the data.
106 patients with NAFLD were enrolled. The median stiffness values using ElastPQ was 4.69 kPa (2.82-29.86). The mean liver stiffness divided for category of fibrosis stage were: 4.18 kPa (mild fibrosis F0-1), 4.49 kPa (significant fibrosis F2), 6.89 kPa >(advanced fibrosis F3) and 12.14 kPa (cirrhosis F4). In multivariate analysis, liver stiffness was associated with the fibrosis stage (ß=2.987; p<0.001). The AUCs for the association with significant, advanced fibrosis and cirrhosis were 0.783 (95%IC 0.693-0.857), 0.855 (95%IC 0.773-
0.916) and 0.897 (95%IC 0.822-0.947), respectively. Diagnostic performance of ElastPQ compared to TE, resulted non-inferior in evaluating significant fibrosis (p=0.956), advanced fibrosis (p=0.171) and cirrhosis (p=0.773). ElastPQ had a higher diagnostic performance compared to FIB-4, NFS and AAR. The best fibrosis cuts off identified in the training cohort (80 patients enrolled) were 5.22 kPa, 6.3 kPa and 9.61 kPa respectively for fibrosis >F2, >F3 and F4. ElastPQ is a promising technique for liver fibrosis evaluation
Abstract
Non-alcoholic fatty liver disease (NAFLD) is the most common cause of chronic liver disease. Several non-invasive approaches to stage liver fibrosis in NAFLD patients are being developed. Elastography Point Quantification (ElastPQ) is a non-invasive method to assess liver fibrosis measuring liver stiffness.
We evaluated the diagnostic performance of ElastPQ for identifying different degrees of fibrosis in NAFLD patients. We compared ElastPQ with other non-invasive tests and identify the best liver stiffness cut offs for every fibrosis stage.
ElastPQ was performed in a training cohort of patients with biopsy-proved NAFLD, liver serum tests and Transient Elastography (TE). The diagnostic performance of ElastPQ was evaluated using AUROC and compared with TE, Fibrosis-4 score, NAFLD fibrosis score and AST/ALT. ElastPQ was performed in a validation cohort in order to validate the data.
106 patients with NAFLD were enrolled. The median stiffness values using ElastPQ was 4.69 kPa (2.82-29.86). The mean liver stiffness divided for category of fibrosis stage were: 4.18 kPa (mild fibrosis F0-1), 4.49 kPa (significant fibrosis F2), 6.89 kPa >(advanced fibrosis F3) and 12.14 kPa (cirrhosis F4). In multivariate analysis, liver stiffness was associated with the fibrosis stage (ß=2.987; p<0.001). The AUCs for the association with significant, advanced fibrosis and cirrhosis were 0.783 (95%IC 0.693-0.857), 0.855 (95%IC 0.773-
0.916) and 0.897 (95%IC 0.822-0.947), respectively. Diagnostic performance of ElastPQ compared to TE, resulted non-inferior in evaluating significant fibrosis (p=0.956), advanced fibrosis (p=0.171) and cirrhosis (p=0.773). ElastPQ had a higher diagnostic performance compared to FIB-4, NFS and AAR. The best fibrosis cuts off identified in the training cohort (80 patients enrolled) were 5.22 kPa, 6.3 kPa and 9.61 kPa respectively for fibrosis >F2, >F3 and F4. ElastPQ is a promising technique for liver fibrosis evaluation
Tipologia del documento
Tesi di dottorato
Autore
Cevenini, Monica
Supervisore
Dottorato di ricerca
Ciclo
34
Coordinatore
Settore disciplinare
Settore concorsuale
Parole chiave
liver fibrosis, NAFLD, liver elastography
URN:NBN
DOI
10.48676/unibo/amsdottorato/10112
Data di discussione
24 Marzo 2022
URI
Altri metadati
Tipologia del documento
Tesi di dottorato
Autore
Cevenini, Monica
Supervisore
Dottorato di ricerca
Ciclo
34
Coordinatore
Settore disciplinare
Settore concorsuale
Parole chiave
liver fibrosis, NAFLD, liver elastography
URN:NBN
DOI
10.48676/unibo/amsdottorato/10112
Data di discussione
24 Marzo 2022
URI
Statistica sui download
Gestione del documento: